Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 10,000 | 0 | 0 |
| Gross Profit | N/A | N/A | 10,000 | N/A | N/A |
| Operating Expenses | 52,580 | 55,163 | 47,330 | 60,624 | 40,984 |
| Operating Income | -52,580 | -55,163 | -37,330 | -55,624 | -40,984 |
| Other Income | 1,081 | 2,960 | 3,552 | 3,448 | 2,378 |
| Pre-tax Income | -51,499 | -52,203 | -33,778 | -52,176 | -38,606 |
| Income Tax | N/A | 20 | -205 | N/A | N/A |
| Net Income Continuous | -51,499 | -52,223 | -33,573 | -52,605 | -38,606 |
| Net Income | $-51,499 | $-52,223 | $-33,573 | $-52,605 | $-38,606 |
| EPS Basic Total Ops | -1.22 | -1.25 | -0.80 | 35.25 | -5.02 |
| EPS Basic Continuous Ops | -1.22 | -1.25 | -0.80 | 35.25 | -5.02 |
| EPS Diluted Total Ops | -1.22 | -1.25 | -0.80 | 35.25 | -5.02 |
| EPS Diluted Continuous Ops | -1.22 | -1.25 | -0.80 | 35.25 | -5.02 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.25 | -0.80 | N/A | -5.02 |
| EBITDA(a) | $-52,569 | $-55,151 | $-37,307 | $-60,591 | $-40,948 |